S G Ellis

Summary

Affiliation: Cleveland Clinic Foundation
Country: USA

Publications

  1. ncbi Relation of operator volume and experience to procedural outcome of percutaneous coronary revascularization at hospitals with high interventional volumes
    S G Ellis
    Cleveland Clinic Foundation, Ohio 44195, USA
    Circulation 95:2479-84. 1997
  2. ncbi Review of immediate angioplasty after fibrinolytic therapy for acute myocardial infarction: insights from the RESCUE I, RESCUE II, and other contemporary clinical experiences
    S G Ellis
    Cleveland Clinic Foundation, OH 44195, USA
    Am Heart J 139:1046-53. 2000
  3. ncbi Relation between lesion characteristics and risk with percutaneous intervention in the stent and glycoprotein IIb/IIIa era: An analysis of results from 10,907 lesions and proposal for new classification scheme
    S G Ellis
    Department of Cardiology, The Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Circulation 100:1971-6. 1999
  4. ncbi Comparing physician-specific two-year patient outcomes after coronary angiography: methodologic issues and results
    S G Ellis
    Department of Cardiology, Cleveland Clinic Foundation, Ohio 44195, USA
    J Am Coll Cardiol 33:1278-85. 1999
  5. ncbi Reduction in complications of angioplasty with abciximab occurs largely independently of baseline lesion morphology. EPIC and EPILOG Investigators. Evaluation of 7E3 for the Prevention of Ischemic Complications. Evaluation of PTCA To Improve Long-term Out
    S G Ellis
    Department of Cardiology, The Cleveland Clinic Foundation, Ohio 44195, USA
    J Am Coll Cardiol 32:1619-23. 1998
  6. ncbi Cost of cardiac care in the three years after coronary catheterization in a contained care system: critical determinants and implications
    S G Ellis
    Department of Cardiology, The Cleveland Clinic Foundation, OH 44195, USA
    J Am Coll Cardiol 31:1306-13. 1998
  7. ncbi Contemporary percutaneous treatment of unprotected left main coronary stenoses: initial results from a multicenter registry analysis 1994-1996
    S G Ellis
    The Cleveland Clinic Foundation, Ohio 44195, USA
    Circulation 96:3867-72. 1997
  8. ncbi The importance of proteinuria as a determinant of mortality following percutaneous coronary revascularization in diabetics
    S P Marso
    Department of Cardiology, Cleveland Clinic Foundation, Ohio 44195, USA
    J Am Coll Cardiol 33:1269-77. 1999
  9. ncbi beta-blockers before percutaneous coronary intervention do not attenuate postprocedural creatine kinase isoenzyme rise
    S G Ellis
    Department of Cardiology, The Cleveland Clinic Foundation, Cleveland, Ohio, USA
    Circulation 104:2685-8. 2001
  10. ncbi Long-term protection from myocardial ischemic events in a randomized trial of brief integrin beta3 blockade with percutaneous coronary intervention. EPIC Investigator Group. Evaluation of Platelet IIb/IIIa Inhibition for Prevention of Ischemic Complicatio
    E J Topol
    Department of Cardiology, Cleveland Clinic Foundation, Ohio 44195, USA
    JAMA 278:479-84. 1997

Detail Information

Publications25

  1. ncbi Relation of operator volume and experience to procedural outcome of percutaneous coronary revascularization at hospitals with high interventional volumes
    S G Ellis
    Cleveland Clinic Foundation, Ohio 44195, USA
    Circulation 95:2479-84. 1997
    ....
  2. ncbi Review of immediate angioplasty after fibrinolytic therapy for acute myocardial infarction: insights from the RESCUE I, RESCUE II, and other contemporary clinical experiences
    S G Ellis
    Cleveland Clinic Foundation, OH 44195, USA
    Am Heart J 139:1046-53. 2000
    ..Because the results of percutaneous coronary intervention (PCI) for MI seem to be improving, a reevaluation of the role of PCI after fibrinolytic therapy for MI appears to be warranted...
  3. ncbi Relation between lesion characteristics and risk with percutaneous intervention in the stent and glycoprotein IIb/IIIa era: An analysis of results from 10,907 lesions and proposal for new classification scheme
    S G Ellis
    Department of Cardiology, The Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Circulation 100:1971-6. 1999
    ..Major advances in treatment options would suggest that this scheme may be outmoded, but the schemes that have been suggested to update lesion classification have not been widely accepted...
  4. ncbi Comparing physician-specific two-year patient outcomes after coronary angiography: methodologic issues and results
    S G Ellis
    Department of Cardiology, Cleveland Clinic Foundation, Ohio 44195, USA
    J Am Coll Cardiol 33:1278-85. 1999
    ..We sought to evaluate methodologies to compare physician-related long-term patient outcomes appropriately...
  5. ncbi Reduction in complications of angioplasty with abciximab occurs largely independently of baseline lesion morphology. EPIC and EPILOG Investigators. Evaluation of 7E3 for the Prevention of Ischemic Complications. Evaluation of PTCA To Improve Long-term Out
    S G Ellis
    Department of Cardiology, The Cleveland Clinic Foundation, Ohio 44195, USA
    J Am Coll Cardiol 32:1619-23. 1998
    ....
  6. ncbi Cost of cardiac care in the three years after coronary catheterization in a contained care system: critical determinants and implications
    S G Ellis
    Department of Cardiology, The Cleveland Clinic Foundation, OH 44195, USA
    J Am Coll Cardiol 31:1306-13. 1998
    ..We sought to determine the clinical, angiographic, treatment and outcome correlates of the intermediate-term cost of caring for patients with suspected coronary artery disease (CAD)...
  7. ncbi Contemporary percutaneous treatment of unprotected left main coronary stenoses: initial results from a multicenter registry analysis 1994-1996
    S G Ellis
    The Cleveland Clinic Foundation, Ohio 44195, USA
    Circulation 96:3867-72. 1997
    ..Selected single-center reports suggest that the results of percutaneous intervention may now approach those of CABG...
  8. ncbi The importance of proteinuria as a determinant of mortality following percutaneous coronary revascularization in diabetics
    S P Marso
    Department of Cardiology, Cleveland Clinic Foundation, Ohio 44195, USA
    J Am Coll Cardiol 33:1269-77. 1999
    ..The aims of this study were to compare mortality and clinical events following percutaneous coronary intervention (PCI) between nondiabetics and diabetics with and without proteinuria...
  9. ncbi beta-blockers before percutaneous coronary intervention do not attenuate postprocedural creatine kinase isoenzyme rise
    S G Ellis
    Department of Cardiology, The Cleveland Clinic Foundation, Cleveland, Ohio, USA
    Circulation 104:2685-8. 2001
    ..The cogency of such a conclusion is dependent on the ability to risk-adjust for the multiple differences in patients treated with and without BBs...
  10. ncbi Long-term protection from myocardial ischemic events in a randomized trial of brief integrin beta3 blockade with percutaneous coronary intervention. EPIC Investigator Group. Evaluation of Platelet IIb/IIIa Inhibition for Prevention of Ischemic Complicatio
    E J Topol
    Department of Cardiology, Cleveland Clinic Foundation, Ohio 44195, USA
    JAMA 278:479-84. 1997
    ..A randomized, placebo-controlled study showed that abciximab improves outcomes for patients undergoing percutaneous coronary angioplasty at 30 days and at 6 months...
  11. ncbi Predictors of death and reinfarction at 30 days after primary angioplasty: the GUSTO IIb and RAPPORT trials
    S J Brener
    The Cleveland Clinic, Cleveland, Ohio, USA
    Am Heart J 139:476-81. 2000
    ..Similar data for primary angioplasty are not available...
  12. ncbi Prognostic value of absolute versus relative measures of the procedural result after successful coronary stenting: importance of vessel size in predicting long-term freedom from target vessel revascularization
    K M Ziada
    Department of Cardiology, Cleveland Clinic Foundation, OH, USA
    Am Heart J 141:823-31. 2001
    ..This emphasizes the role of the vessel size as the limiting factor in determining the long-term outcome of coronary stenting...
  13. ncbi Predictors and prognosis of suboptimal coronary blood flow after primary coronary angioplasty in patients with acute myocardial infarction
    F A Cura
    Department of Cardiology, The Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Am J Cardiol 88:124-8. 2001
    ..Conversely, the presence of normal or near-normal coronary flow before intervention correlates with a good angiographic result. Mortality risk is increased in patients with postprocedural suboptimal angiographic coronary flow...
  14. ncbi Incremental prognostic value of elevated baseline C-reactive protein among established markers of risk in percutaneous coronary intervention
    D P Chew
    Department of Cardiology, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Circulation 104:992-7. 2001
    ..Coupled anatomic, clinical, and inflammatory risk stratification demonstrates strong predictive utility among patients undergoing percutaneous coronary intervention and may be useful for guiding future strategies...
  15. ncbi Ticlopidine pretreatment before coronary stenting is associated with sustained decrease in adverse cardiac events: data from the Evaluation of Platelet IIb/IIIa Inhibitor for Stenting (EPISTENT) Trial
    S R Steinhubl
    Department of Cardiology, Wilford Hall Medical Center, Lackland AFB, TX 78236, USA
    Circulation 103:1403-9. 2001
    ..The role of enhanced antiplatelet protection through pretreatment with the platelet ADP-receptor antagonist ticlopidine in preventing both the early and late complications of coronary stenting has not previously been explored...
  16. ncbi Proteinuria is a key determinant of death in patients with diabetes after isolated coronary artery bypass grafting
    S P Marso
    Department of Cardiology, The Cleveland Clinic Foundation, OH, USA
    Am Heart J 139:939-44. 2000
    ..We hypothesized that diabetic patients with evidence of proteinuria would have increased mortality and clinical event rates after isolated coronary artery bypass grafting compared with nonproteinuric diabetic patients...
  17. ncbi Intracoronary stenting: an overview for the clinician
    S P Marso
    Department of Cardiology, Cleveland Clinic, Ohio 44195, USA
    Cleve Clin J Med 66:434-42. 1999
    ..But it has drawbacks, such as in-stent restenosis, high cost, and lack of long-term follow-up data. This paper discusses current indications and the future role of stenting...
  18. ncbi New options for untreatable coronary artery disease: angiogenesis and laser revascularization
    D Mukherjee
    Department of Cardiology, Cleveland Clinic, USA
    Cleve Clin J Med 67:577-83. 2000
    ....
  19. ncbi Clinical outcome of a cohort of patients eligible for therapeutic angiogenesis or transmyocardial revascularization
    D Mukherjee
    Department of Cardiology, University of Michigan, USA
    Am Heart J 142:72-4. 2001
    ..5% rate of myocardial infarction (15 of 59), and a mortality rate of 16.9% (10 of 59). CONCLUSIONS: The prognosis of many patients eligible for newer methods of revascularization on maximal medical therapy is poor...
  20. ncbi Facilitated PCI in patients with ST-elevation myocardial infarction
    Stephen G Ellis
    Department of Cardiovascular Medicine, The Cleveland Clinic, F25, 9500 Euclid Ave, Cleveland, OH 44195, USA
    N Engl J Med 358:2205-17. 2008
    ....
  21. ncbi Frequency and long-term impact of myonecrosis after coronary stenting
    S J Brener
    Department of Cardiology, Cleveland Clinic Foundation, Cleveland, Ohio, USA
    Eur Heart J 23:869-76. 2002
    ..Intensive efforts to reduce creatine kinase MB elevation after revascularization are warranted and should lead to important benefits...
  22. ncbi Accreditation of hospitals for percutaneous coronary intervention on the basis of volume or clinical outcome using MEDPAR data sets: effect on patient mortality, cost and treatment accessibility
    S G Ellis
    The Cleveland Clinic Foundation, 9500 Euclid Avenue, F 25, Cleveland, OH 44195, USA
    J Invasive Cardiol 12:464-71. 2000
    ..We sought to ascertain the effect of credentialing hospitals for PCR, either on the basis of procedural volume or outcome, on clinical outcome, cost and accessibility to treatment, in states of varied population density...
  23. ncbi Immediate sealing of arterial puncture sites after cardiac catheterization and coronary interventions: initial U.S. feasibility trial using the Duett vascular closure device
    M R Mooney
    Department of Cardiology, Mpls Heart Institute Foundation, Minneapolis, MN 55407, USA
    Catheter Cardiovasc Interv 50:96-102. 2000
    ..There were no other major complications. This novel vascular sealing device appears to achieve rapid and safe hemostasis successfully immediately following a wide range of percutaneous endovascular procedures...
  24. ncbi Long-term clinical outcomes after unprotected left main trunk percutaneous revascularization in 279 patients
    W A Tan
    Pittsburgh Vascular Institute, UPMC Shadyside, Pittsburgh, PA, USA
    Circulation 104:1609-14. 2001
    ..Meticulous follow-up of hospital survivors is required because of the rather high mortality during the first few months after treatment...
  25. ncbi Effect of PCI on quality of life in patients with stable coronary disease
    William S Weintraub
    Christiana Care Health System, Newark, DE 19718, USA
    N Engl J Med 359:677-87. 2008
    ..It has not been clearly established whether percutaneous coronary intervention (PCI) can provide an incremental benefit in quality of life over that provided by optimal medical therapy among patients with chronic coronary artery disease...